Synthesized economic evidence on the cost-effectiveness of screening familial hypercholesterolemia.

ABSTRACT:

Background

Familial hypercholesterolemia (FH) is a prevalent genetic disorder with global implications for severe cardiovascular diseases. Motivated by the growing recognition of the need for early diagnosis and treatment of FH to mitigate its severe consequences, alongside the gaps in understanding the economic implications and equity impacts of FH screening, this study aims to synthesize the economic evidence on the cost-effectiveness of FH screening and to analyze the impact of FH screening on health inequality.

Methods

We conducted a systematic review on the economic evaluations of FH screening and extracted information from the included studies using a pre-determined form for evidence synthesis. We synthesized the cost-effectiveness components involving the calculation

SUBMITTER: Wang M 

PROVIDER: S-EPMC11425997 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature